CD34 and B-cell chronic lymphocytic leukemia: We lyzed multiple CLL patient’s PBMCs from chemo naïve, treated with either the combination of bendamustine and rituximab or FCR, and then the samples were processed for immunoblotting to determine the expression of GCS and CD34.